Amplicorepharma
1 known investors
Find your way into Amplicorepharma
Amplicore Pharma develops an injectable pharmaceutical formulation targeting musculoskeletal disorders, particularly osteoarthritis, designed to slow cartilage degeneration and reduce symptoms as an alternative to joint replacement surgery.
Founders & leadership
TC
Tina ChenDirector of Clinical Affairs
Investors · 1
Berkeley Catalystlisted by Berkeley CatalystBerkeley
How we know: the VCSheet dataset · Not right? Tell us
Frequently asked questions
- What does Amplicorepharma do?
- Amplicore Pharma develops an injectable pharmaceutical formulation targeting musculoskeletal disorders, particularly osteoarthritis, designed to slow cartilage degeneration and reduce symptoms as an alternative to joint replacement surgery.
- Who are Amplicorepharma's investors?
- Amplicorepharma's investors include Berkeley Catalyst.
